期刊文献+

IDO基因稳定转染HepG_2细胞系的建立 被引量:3

Construction of a HepG_2 Cell Line with IDO Gene Steady Transfection
下载PDF
导出
摘要 目的建立稳定转染IDO基因的HepG2细胞系,为进一步研究IDO基因在肝癌免疫逃逸中的作用奠定基础。方法应用脂质体将真核细胞表达质粒pcDNA3.1-IDO和空载质粒pcDNA3.1转染入HepG2细胞,经G418进行筛选后,挑取单克隆进行培养,用反转录酶聚合酶链反应(RT-PCR)和Western blot方法验证获得的表达细胞株。结果经RT-PCR和Western blotting检测证实空质粒转染组和空白对照组HepG2细胞无IDO基因及蛋白的表达,而重组质粒组的HepG2细胞表达IDO基因和蛋白。结论 pcDNA3.1-IDO质粒体外稳定转染人肝癌细胞HepG2,可以有效地使IDO基因在RNA水平和蛋白水平均表达,成功建立了稳定转染基因IDO的HepG2细胞系,为进一步探讨该基因的功能奠定了一定基础。 Objective To establish a human hepatoma carcinoma cell line with IDO gene steady transfection and verify the gene expression of IDO in HepG2 cell,which provides the foundation for the tumorous immune escape effect of pcDNA3.1-IDO.Methods The eukaryotic expression plasmid pcDNA3.1-IDO and empty vector pcDNA3.1 were transfected into HepG2 cells with lipofectine.G418 was used for selecting the positive clone.After being screened with G418,the single cell clone was sought out and cultured.The expression of IDO in HepG2 cells was detected by reverse transcription polymerase chain reaction(RT-PCR) and Western blotting.Results Not only at the level of transcription but also translation,IDO gene expressed in IDO transfectant confirmed by RT-PCR and Western blotting respectively.Conclusion Stabily transfected HepG2 of pcDNA3.1-IDO Plasmid can lead to upregulating IDO mRNA and protein expression obviously,which showes transfection HepG2 of pcDNA3.1-IDO successfully.
出处 《医学研究杂志》 2012年第2期68-70,共3页 Journal of Medical Research
基金 山西省科研攻关项目(200903110)
关键词 吲哚胺2 3-双加氧酶(IDO) HEPG2细胞 稳定转染 Indoleamine 2 3-dioxygenase(IDO) HepG2 cell Steady transfection
  • 相关文献

参考文献10

  • 1Mellor AL,Munn DH.Tryptophan catabolism and T_cell tolerance:im-mune-suppression by strvationK?[J].Immunol Today,1999,20(10):469-473.
  • 2Puccetti P,Grohmann U.IDO and regulatory T cells:a role for reversesignaling and non-canonical NF-kappaB activation[J].Nat RevImmunol,2007,7(10):817-823.
  • 3Schroecksnadel K,Zangerle R,Bellmann-Weiler R,et al.Indoleam-ine-2,3-dioxygenase and other interferon-gamma-mediatedpathways in patients with human immunodeficiency virus infection[J].Curr Drug Metab,2007,8(3):225-236.
  • 4Brandacher G,Perathoner A,Ladurner R,et al.Prognostic value of in-doleamine 2,3-dioxygenase expression in colorectal cancer:effect ontumor-infiltrating T cells[J].Clin Cancer Res,2006,12(4):1144-1151.
  • 5Ino K,Yoshida N,Kajiyama H,et al.Indoleamine-2,3-dioxygenaseis a novel prognostic indicator for endometrial cancer[J].Br J Cancer,2006,95(11):1555-1561.
  • 6Nakamura T,Shima T,Saeki A,et al.Expression of indoleamine-2,3-dioxygenase and the recruitment of Foxp3-expressing regulatory Tcells in the development and progression of uterine cervical cancer[J].Cancer Sci,2007,98(6):874-881.
  • 7Nonaka H,Saga Y,Fujiwara H,et al.Indoleamine 2,3-dioxygenasepromotes peritoneal dissemination of ovarian cancer through inhibitionof natural killercell function and angiogenesis promotion[J].Int J On-col,2011,38(1):113-120.
  • 8Ishio T,Goto S,Tahara K,et al.Immunoactivative role of indoleamine2,3-dioxygenase in human hepatocellular carcinoma[J].J Gastroen-terol Hepatol,2004,19(3):319-326.
  • 9武亚娟,王琦,武希润,董胜利,刘晓丽,张晓琴.吲哚胺2,3-双加氧酶在肝癌组织的表达及其临床意义[J].中国肿瘤生物治疗杂志,2008,15(6):585-587. 被引量:2
  • 10康璇,王琦,杨洁.吲哚胺2,3双-加氧酶介导肝癌细胞免疫逃逸的实验研究[J].中国生物工程杂志,2008,28(5):12-16. 被引量:2

二级参考文献20

  • 1唐晓琼,赵智刚,王红祥,李秋柏,吕建,邹萍华.急性髓细胞白血病细胞的吲哚胺2,3-双加氧酶介导免疫逃逸的实验研究[J].中国实验血液学杂志,2006,14(3):539-542. 被引量:7
  • 2Terness P, Chuang JJ, Bauer T, et al. Regulation of human auto-and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO[J]? Blood, 2005, 105(6): 2480-2486.
  • 3Ishio T, Goto S, Tahara K, et al. Immunoaetivative role of indoleamine 2, 3-dioxygenase in human hepato-cellular carcinoma[J]. J Gastroenterol Hepatol, 2004, 19(3) : 319-326.
  • 4Uyttenhove C, Pilotte L, Theate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[J]. Nat Med, 2003, 9(10) : 1269-1274.
  • 5Hou DY, Muller AJ, Sharma MD, et al. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses[J].Cancer Res, 2007,67 (2) : 792-801.
  • 6Ino K, Yamamoto E, Shibata K,et al. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival[J]. Clin Cancer Res, 2008, 14 (8) :2310-2317.
  • 7Muller A J, Duhadaway JB, Donover PS, et al. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Binl, potentiates cancer chemother-apy[J]. Nat Med, 2005, 11(3): 312-319.
  • 8Pan K, Wang H, Chen MS, et al. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma [J]. J Cancer Res Clin Oncol, 2008, 134(11) : 1247-1253.
  • 9Munn DH, Sharma MD, Hou D, et al. Expression of indoleamine 2,3-dioxygemase by plasmacytoid dendritic cells in tumor-draining lymph nodes [ J ]. J Chin Invest, 2004,114 (2) : 280-290.
  • 10Astigiano S, Morandi B, Costa R, et al. Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-midiated immune escape in human non-small cell lung cancer[J].Neoplasia, 2005, 7(4) : 390-396.

共引文献2

同被引文献9

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部